METHOD OF TREATING MULTIPLE MYELOMA

Provided herein are methods of treating multiple myeloma and methods of inhibiting amyloid formation in a subject. The methods provided herein include the administration of an antibody that binds to misfolded light chains in combination with an anti-CD38 antibody. The anti-CD38 is for example Daratu...

Full description

Saved in:
Bibliographic Details
Main Authors SPECTOR, Michael, SOBOLOV-JAYNES, Susan
Format Patent
LanguageEnglish
French
Published 23.03.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Provided herein are methods of treating multiple myeloma and methods of inhibiting amyloid formation in a subject. The methods provided herein include the administration of an antibody that binds to misfolded light chains in combination with an anti-CD38 antibody. The anti-CD38 is for example Daratumumab, Isatuximab, CID- 103 (CASI Pharma), or Moro3087 (Morphosys) or a combination thereof. L'invention concerne des méthodes de traitement du myélome multiple et des méthodes d'inhibition de la formation d'amyloïdes chez un sujet. Les méthodes de l'invention comprennent l'administration d'un anticorps qui se lie à des chaînes légères à repliement incorrect en combinaison avec un anticorps anti-CD38. L'anti-CD38 est par exemple le Daratumumab, l'Isatuximab, le CID-103 (CASI Pharma), ou le Moro3087 (Morphosys) ou une combinaison de ceux-ci.
Bibliography:Application Number: WO2022US42944